Advisor Group Holdings, Inc. Statera Biopharma, Inc. Transaction History

Advisor Group Holdings, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$0.08 - $0.15 $1,180 - $2,213	14,755 Added 94.92%	30,300 $2,000
Q3 2022 Nov 14, 2022	BUY	$0.15 - $0.28 $2,247 - $4,194	14,980 Added 2651.33%	15,545 $2,000
Q2 2022 Aug 10, 2022	BUY	$0.21 - $0.38 $118 - $214	565 New	565 $0
Q1 2022 May 04, 2022	SELL	$0.31 - $2.27 $89 - $658	-290 Closed	0 $0
Q3 2021 Nov 05, 2021	BUY	$2.29 - $6.24 $664 - $1,809	290 New	290 $1,000

30K

Ticker STAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,295,700
Description
Statera BioPharma, Inc., a clinical-stage biopharmaceutical company, develops novel immunotherapies targeting autoimmune, neutropenia/anemia, emerging viruses, and cancers based on a proprietary platform designed to rebalance the body's immune system and restore homeostasis. The company is developing therapies designed to directly elicit within ...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.